Latest Content

In the phase 3 ATHENA-MONO trial, 5-year data show Rubraca helped delay cancer worsening in advanced ovarian cancer vs placebo.

A living liver donor shares recovery challenges, emotional rewards and advice for those considering donation to help save a life.

KRAS G12d-targeted protein degrader setidegrasib demonstrated antitumor activity and a manageable safety profile in patients with KRAS G12d-mutant non–small cell lung cancer.

Functional precision medicine may help guide faster, more personalized treatment decisions in pediatric brain tumors by testing therapies directly on a patient’s tumor cells.

Nurse practitioner Bridget Hopkins discusses her metastatic breast cancer diagnosis, the role of clinical empathy and finding hope in stage 4 care.

In the last month, I had a revelation about my illness.

FDA approved Lifyorli plus Abraxane, improving survival in platinum-resistant ovarian, fallopian tube and peritoneal cancers.

Five-year ICESECRET data show high recurrence-free rates with cryoablation for small kidney tumors, supporting a minimally invasive treatment option.

Amanda shares how a sudden leukemia diagnosis led to a life-saving transplant and the ongoing challenges of chronic graft-versus-host disease.

ctDNA testing could help doctors track response, reduce unnecessary chemo, and identify relapse early for patients with aggressive B cell lymphomas.

For patients navigating a cancer diagnosis, there is a hidden complication that requires vigilance: the risk of a pulmonary embolism.

For me, Colorectal Cancer Awareness Month is about my brother, Jimmy, who died from colorectal cancer at the age of 36.

New findings from the phase 3 SENTRY trial offer encouraging news for patients with myelofibrosis.